Monkeypox and other zoonotic diseases in the DRC
Official title: RFA-CK-22-001, Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) - 2022
Funded at Kinshasa School of Public Health · NIH-11393414 · Data updated 2026-11-12
Aimed at reducing the impact of monkeypox and related diseases in the Democratic Republic of the Congo by improving data, training public health workers, and testing new diagnostics and therapies.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kinshasa School of Public Health NIH-funded |
| Lab location | 1 site (Kinshasa, Congo Dem Rep) |
| Project start | September 30, 2022 |
| Project end | September 29, 2027 |
| Funding year | 2026 |
| Award (this year) | $250,000 |
| NIH project number | 5U01CK000666-05 |
| Project ID | NIH-11393414 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals in the DRC, especially those at high risk for monkeypox, survivors, and health workers involved in surveillance and care.
✕Less likely to help
People without access to local health systems or in areas not engaged by the project may not directly benefit.
What this research studies
This project focuses on building a more accurate picture of monkeypox in the DRC through lab-based surveillance and serosurveys, while strengthening local public health capacity. It plans to test new training methods for health workers, enhance geographic and case data, and evaluate diagnostic platforms as they become available. Researchers will conduct clinical trials of care regimens, vaccines, and antiviral therapies in collaboration with local health systems and the DRC Ministry of Health. The work also includes identifying wildlife reservoirs and gathering community insights to better understand transmission and prevention. Together, these efforts aim to enable faster outbreak responses and reduce the clinical burden of zoonotic diseases in the region.
Why it matters
Potential benefit: If successful, patients and communities in the DRC could benefit from faster outbreak detection, improved clinical care, and better prevention strategies for monkeypox and related diseases.
How similar studies have gone: Prior efforts have shown that enhanced surveillance and training can improve outbreak response and inform vaccination and treatment strategies in similar settings.
Where this research is happening
-
Kinshasa School of Public Health
Kinshasa, Congo Dem Rep Active
Researchers
- Principal investigator: Kaba, Didine Kinkodi — Kinshasa School of Public Health
- Study coordinator: Kaba, Didine Kinkodi
Related research
Other NIH-funded projects on the same topics.
-
Understanding Monkeypox and other diseases in the Democratic Republic of the Congo
This study is working to better understand Monkeypox and similar diseases in the Democratic Republic of the Congo by training health workers, improving how we collect data, and testing new ways to diagnose and treat these illnesses, all to help keep communities safe during outbreaks.
-
Understanding Monkeypox and other diseases in the Democratic Republic of the Congo
This study is working to better understand Monkeypox and similar diseases in the Democratic Republic of the Congo by training health workers, improving how we collect data, and testing new ways to diagnose and treat these illnesses, all to help keep communities safer during outbreaks.
-
Monkeypox and other animal-to-human infections: surveillance and care in the DRC
This project works to make it easier to find, treat, and prevent monkeypox and other animal-transmitted infections for people living in the Democratic Republic of the Congo.
-
Understanding and reducing monkeypox and other zoonotic diseases in the Democratic Republic of the Congo.
This study is all about learning more about monkeypox and similar diseases in the Democratic Republic of the Congo, so we can better help people affected by them; it includes training health workers, improving testing methods, and finding out how these diseases spread, all while working closely with local communities.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.